MFMichael J. Fassett

Michael J. Fassett

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael J. Fassett has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Health Care Use and Recurrence Rate in Hemolytic Disease of the Fetus and Newborn: Retrospective Cohort Study

    byĀ Nehaa Khadka, Michael J Fassett, Carol Mao, Fagen Xie, Vicki Y Chiu, Jiaxiao M Shi, Theresa M Im, Sunhea Kim, Daniella Park, Darios Getahun

    Background: Hemolytic disease of the fetus and newborn (HDFN) is a life-threatening condition resulting from maternal-fetal erythrocyte antigen incompatibility. Although anti–Rhesus D (RhD) prophylaxis has reduced RhD-associated cases, HDFN persists due to non-RhD antibodies and gaps in prevention. Population-based data on maternal and neonatal outcomes and recurrence patterns are limited. Objective: This study aimed to characterize maternal and neonatal outcomes, health care use patterns, and recurrence rates of HDFN across pregnancies. Methods: We conducted a retrospective cohort study of 464,711 pregnancies within the Kaiser Permanente Southern California system from January 1, 2008, to June 30, 2022. HDFN diagnoses were confirmed using validated natural language processing–assisted manual chart review and followed through 2023. Maternal characteristics, neonatal outcomes, and health care use were compared by HDFN status, and recurrence patterns were evaluated among individuals with ≄2 pregnancies. Chi-square tests and Wilcoxon rank-sum tests were used to compare characteristics between HDFN and non-HDFN pregnancies. Statistical significance was defined as P<.05. Results: Among all pregnancies, 139 of 464,711 (0.03%) were diagnosed with HDFN. Women with HDFN were more likely than those without HDFN to be older (aged ≄35 years; n=42, 30.2% vs n=97,146, 20.9%) and multiparous (n=121, 87.1% vs n=264,766, 57%). Infants affected by HDFN had higher rates of preterm birth (n=40, 28.4% vs n=42,240, 9.5%), low birth weight (<2500 g; n=22, 15.6% vs n=31,740, 7.1%), and neonatal jaundice (n=92, 65.2% vs n=162,465, 36.4%) than non-HDFN infants. Delivery hospitalizations (median 5.0, IQR 2.0-7.5 days vs median 2.0, IQR 1.0-2.0 days) and neonatal intensive care unit stays (median 4.0, IQR 0.0-7.0 days vs median 0.0, IQR 0.0-0.0 days) were longer, and maternal nondelivery hospitalizations were more frequent (n=27, 19.4% vs n=23,228, 5%) among pregnancies complicated by HDFN. Among women with a prior HDFN-affected pregnancy, 83.3% (n=25) experienced recurrence in a subsequent pregnancy. Of these recurrent cases, 32% (n=8) were severe, and 75% (n=6) involved fetal anemia requiring at least 1 intrauterine transfusion. Conclusions: HDFN was rare but was associated with substantial maternal and neonatal morbidity, including higher rates of preterm birth, increased neonatal intensive care unit admissions, and greater health care use. Recurrence was frequent and clinically significant, underscoring the importance of early surveillance and proactive management strategies.

  • Open Access

    Accuracy of Electronic Health Record Derived Maternal and Perinatal Condition Codes in an Integrated Health Care Delivery System: Development and Validation Study (Preprint)

    byĀ Jeniffer S. Kim, Wansu Chen, Michael J. Fassett, Lawrence Lurvey, Meiyu Yeh, Vicki Y. Chiu, Zhi Liang, Nehaa Khadka, Darios Getahun

    BACKGROUND Medical and obstetrical conditions during pregnancy can present serious risks to both the mother and the developing fetus. An accurate electronic health record (EHR) registry database of maternal and fetal conditions is necessary to understand these conditions and find causative factors. OBJECTIVE To evaluate the accuracy of maternal and fetal diagnoses and procedural codes in the EHR database compared to manual chart reviews. METHODS A random sample of 800 charts was selected from eligible records from January 1, 2021, through June 30, 2021. Perinatal outcome data were extracted from Kaiser Permanente Southern California (KPSC) EHRs. A team of trained research associates conducted manual chart review of the same perinatal outcomes, and the abstracted codes were compared with corresponding EHR records. Accuracy differences were then evaluated through sensitivity, specificity, and weighted positive and negative predictive value. RESULTS The accuracy of chart reviews and codes varied by condition. Conditions such as placenta previa, cesarean delivery, chronic hypertension, and gestational diabetes demonstrated high sensitivity (>95%), while others, including chorioamnionitis and gestational fever, showed lower sensitivity, 22% and 27%, respectively. Specificity, weighted PPV, and weighted NPV were acceptable (>85%) for most conditions. CONCLUSIONS The accuracy of EHR coding for maternal and perinatal conditions is variable depending on the condition, with high reliability for certain diagnoses but notable deficiencies for others. These findings highlight the need for targeted efforts to improve coding or diagnostic accuracy, particularly for conditions with low sensitivity, to support more reliable data for clinical decision-making, quality improvement initiatives, and research.

  • Open Access

    Feasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies

    byĀ Nana A Mensah, Michael J Fassett, Nehaa Khadka, Jiaxiao M Shi, Fagen Xie, Vicki Y Chiu, Theresa M Im, Sunhea Kim, Daniella Park, Carol Mao, et al.

    Background: Hemolytic disease of the fetus and newborn (HDFN) is a rare but serious condition caused by maternal-fetal red blood cell antigen incompatibility. In an affected pregnancy, maternal immunoglobulin G antibodies cross the placenta and target fetal or neonatal red blood cells, leading to hemolysis, hyperbilirubinemia, and anemia. Although routine screening and alloimmunization prevention programs have contributed to the decline in HDFN in the United States, further understanding of its epidemiology is still needed. Objective: This protocol aims to provide an overview of the study design, methodology, and analytical approach used to investigate the epidemiology, treatment, and health care resource use of HDFN within a large integrated health care system. Methods: We conducted a retrospective cohort study of pregnant women who received obstetric care in the Kaiser Permanente Southern California (KPSC) health care system from January 1, 2008, to June 30, 2022. To identify HDFN cases, we used a novel methodology developed by KPSC researchers combining structured data and detailed clinical information extracted from unstructured records via a natural language processing–assisted chart review process. Chi-square and Wilcoxon rank sum tests were used to compare the distributions of maternal and infant demographic characteristics, as well as medical and perinatal conditions, by HDFN status. We also evaluated the association between HDFN and adverse perinatal outcomes using logistic regression models. Planned analyses using this unique cohort will include describing the annual prevalence, health care resource use, and treatment patterns of mothers and infants by HDFN status. Results: The study population consisted of 464,711 pregnancies, of which 136 (0.03%) were HDFN cases confirmed by chart review, resulting in 138 (0.03%) births (n=137, 0.99% live births and n=1, 0.01% stillbirth). The mean age at pregnancy was 29.8 (SD 5.7) years, and the population was racially and ethnically diverse. Conclusions: We present an overview of the methodology developed by KPSC clinicians and researchers on the epidemiology, treatment, and health care resource use of HDFN within a large and demographically diverse population of pregnant women. Our novel methodology, combining both structured and unstructured data and a natural language processing–assisted chart review process, ensures the successful identification of true cases to carry out pharmaco-epidemiological studies. International Registered Report Identifier (IRRID): DERR1-10.2196/77836


  • Open Access

    Health Care Use and Recurrence Rate in Hemolytic Disease of the Fetus and Newborn: Retrospective Cohort Study (Preprint)

    byĀ Nehaa Khadka, Michael J Fassett, Carol Mao, Fagen Xie, Vicki Y Chiu, Jiaxiao M Shi, Theresa M Im, Sunhea Kim, Daniella Park, Darios Getahun

    BACKGROUND Hemolytic disease of the fetus and newborn (HDFN) is a life-threatening condition resulting from maternal-fetal erythrocyte antigen incompatibility. Although anti–Rhesus D (RhD) prophylaxis has reduced RhD-associated cases, HDFN persists due to non-RhD antibodies and gaps in prevention. Population-based data on maternal and neonatal outcomes and recurrence patterns are limited. OBJECTIVE This study aimed to characterize maternal and neonatal outcomes, health care use patterns, and recurrence rates of HDFN across pregnancies. METHODS We conducted a retrospective cohort study of 464,711 pregnancies within the Kaiser Permanente Southern California system from January 1, 2008, to June 30, 2022. HDFN diagnoses were confirmed using validated natural language processing–assisted manual chart review and followed through 2023. Maternal characteristics, neonatal outcomes, and health care use were compared by HDFN status, and recurrence patterns were evaluated among individuals with ≄2 pregnancies. Chi-square tests and Wilcoxon rank-sum tests were used to compare characteristics between HDFN and non-HDFN pregnancies. Statistical significance was defined as P<.05. RESULTS Among all pregnancies, 139 of 464,711 (0.03%) were diagnosed with HDFN. Women with HDFN were more likely than those without HDFN to be older (aged ≄35 years; n=42, 30.2% vs n=97,146, 20.9%) and multiparous (n=121, 87.1% vs n=264,766, 57%). Infants affected by HDFN had higher rates of preterm birth (n=40, 28.4% vs n=42,240, 9.5%), low birth weight (<2500 g; n=22, 15.6% vs n=31,740, 7.1%), and neonatal jaundice (n=92, 65.2% vs n=162,465, 36.4%) than non-HDFN infants. Delivery hospitalizations (median 5.0, IQR 2.0-7.5 days vs median 2.0, IQR 1.0-2.0 days) and neonatal intensive care unit stays (median 4.0, IQR 0.0-7.0 days vs median 0.0, IQR 0.0-0.0 days) were longer, and maternal nondelivery hospitalizations were more frequent (n=27, 19.4% vs n=23,228, 5%) among pregnancies complicated by HDFN. Among women with a prior HDFN-affected pregnancy, 83.3% (n=25) experienced recurrence in a subsequent pregnancy. Of these recurrent cases, 32% (n=8) were severe, and 75% (n=6) involved fetal anemia requiring at least 1 intrauterine transfusion. CONCLUSIONS HDFN was rare but was associated with substantial maternal and neonatal morbidity, including higher rates of preterm birth, increased neonatal intensive care unit admissions, and greater health care use. Recurrence was frequent and clinically significant, underscoring the importance of early surveillance and proactive management strategies.

  • Open Access

    Feasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies (Preprint)

    byĀ Nana A Mensah, Michael J Fassett, Nehaa Khadka, Jiaxiao M Shi, Fagen Xie, Vicki Y Chiu, Theresa M Im, Sunhea Kim, Daniella Park, Carol Mao, et al.

    BACKGROUND Hemolytic disease of the fetus and newborn (HDFN) is a rare but serious condition caused by maternal-fetal red blood cell antigen incompatibility. In an affected pregnancy, maternal immunoglobulin G antibodies cross the placenta and target fetal or neonatal red blood cells, leading to hemolysis, hyperbilirubinemia, and anemia. Although routine screening and alloimmunization prevention programs have contributed to the decline in HDFN in the United States, further understanding of its epidemiology is still needed. OBJECTIVE This protocol aims to provide an overview of the study design, methodology, and analytical approach used to investigate the epidemiology, treatment, and health care resource use of HDFN within a large integrated health care system. METHODS We conducted a retrospective cohort study of pregnant women who received obstetric care in the Kaiser Permanente Southern California (KPSC) health care system from January 1, 2008, to June 30, 2022. To identify HDFN cases, we used a novel methodology developed by KPSC researchers combining structured data and detailed clinical information extracted from unstructured records via a natural language processing–assisted chart review process. Chi-square and Wilcoxon rank sum tests were used to compare the distributions of maternal and infant demographic characteristics, as well as medical and perinatal conditions, by HDFN status. We also evaluated the association between HDFN and adverse perinatal outcomes using logistic regression models. Planned analyses using this unique cohort will include describing the annual prevalence, health care resource use, and treatment patterns of mothers and infants by HDFN status. RESULTS The study population consisted of 464,711 pregnancies, of which 136 (0.03%) were HDFN cases confirmed by chart review, resulting in 138 (0.03%) births (n=137, 0.99% live births and n=1, 0.01% stillbirth). The mean age at pregnancy was 29.8 (SD 5.7) years, and the population was racially and ethnically diverse. CONCLUSIONS We present an overview of the methodology developed by KPSC clinicians and researchers on the epidemiology, treatment, and health care resource use of HDFN within a large and demographically diverse population of pregnant women. Our novel methodology, combining both structured and unstructured data and a natural language processing–assisted chart review process, ensures the successful identification of true cases to carry out pharmaco-epidemiological studies. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/77836

  • Open Access

    Postpartum Depression Increases the Risk of Autism Diagnosis in the Offspring

    byĀ Morgan R. Peltier, Michael J. Fassett, Nana A. Mensah, Nehaa Khadka, Meiyu Yeh, Vicki Y. Chiu, Yinka Oyelese, Darios Getahun


  • Racial Disparities in Severe Maternal Morbidity in an Integrated Health Care System, Southern California, 2008–2017

    byĀ Lisa.P. Oakley, Xia Li, Sara Y. Tartof, Madalynne Wilkes-Grundy, Michael J. Fassett, Jean M. Lawrence


  • Open Access

    Postpartum Migraine Headache Coding in Electronic Health Records of a Large Integrated Health Care System: Validation Study

    byĀ Jiaxiao Shi, Michael J Fassett, Vicki Y Chiu, Chantal C Avila, Nehaa Khadka, Brittany Brown, Pooja Patel, Nana Mensah, Fagen Xie, Morgan R Peltier, et al.

    Background: Migraine is a common neurological disorder characterized by repeated headaches of varying intensity. The prevalence and severity of migraine headaches disproportionally affects women, particularly during the postpartum period. Moreover, migraines during pregnancy have been associated with adverse maternal outcomes, including preeclampsia and postpartum stroke. However, due to the lack of a validated instrument for uniform case ascertainment on postpartum migraine headache, there is uncertainty in the reported prevalence in the literature. Objective: The aim of this study was to evaluate the completeness and accuracy of reporting postpartum migraine headache coding in a large integrated health care system’s electronic health records (EHRs) and to compare the coding quality before and after the implementation of the International Classification of Diseases, 10th revision, Clinical Modification (ICD-10-CM) codes and pharmacy records in EHRs. Methods: Medical records of 200 deliveries in all 15 Kaiser Permanente Southern California hospitals during 2 time periods, that is, January 1, 2012 through December 31, 2014 (International Classification of Diseases, 9th revision, Clinical Modification [ICD-9-CM] coding period) and January 1, 2017 through December 31, 2019 (ICD-10-CM coding period), were randomly selected from EHRs for chart review. Two trained research associates reviewed the EHRs for all 200 women for postpartum migraine headache cases documented within 1 year after delivery. Women were considered to have postpartum migraine headache if either a mention of migraine headache (yes for diagnosis) or a prescription for treatment of migraine headache (yes for pharmacy records) was noted in the electronic chart. Results from the chart abstraction served as the gold standard and were compared with corresponding diagnosis and pharmacy prescription utilization records for both ICD-9-CM and ICD-10-CM coding periods through comparisons of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), as well as the summary statistics of F-score and Youden J statistic (J). The kappa statistic (Īŗ) for interrater reliability was calculated. Results: The overall agreement between the identification of migraine headache using diagnosis codes and pharmacy records compared to the medical record review was strong. Diagnosis coding (F-score=87.8%; J=82.5%) did better than pharmacy records (F-score=72.7%; J=57.5%) when identifying cases, but combining both of these sources of data produced much greater accuracy in the identification of postpartum migraine cases (F-score=96.9%; J=99.7%) with sensitivity, specificity, PPV, and NPV of 100%, 99.7%, 93.9%, and 100%, respectively. Results were similar across the ICD-9-CM (F-score=98.7%, J=99.9%) and ICD-10-CM coding periods (F-score=94.9%; J=99.6%). The interrater reliability between the 2 research associates for postpartum migraine headache was 100%. Conclusions: Neither diagnostic codes nor pharmacy records alone are sufficient for identifying postpartum migraine cases reliably, but when used together, they are quite reliable. The completeness of the data remained similar after the implementation of the ICD-10-CM coding in the EHR system.


  • Open Access

    Accuracy of Reporting Postpartum Migraine Headaches Coding in Electronic Health Records of a Large Integrated Healthcare System (Preprint)

    byĀ Jiaxiao Shi, Michael J. Fassett, Vicki Y. Chiu, Chantal C. Avila, Nehaa Khadka, Brittany Brown, Pooja Patel, Nana Mensah, Fagen Xie, Morgan R. Peltier, et al.

    BACKGROUND Migraine is a common neurological disorder characterized by repeated headaches of varying intensity, particularly during the postpartum period for women. However, due to lack of a validated instrument for uniform case ascertainment on postpartum migraine headache, there is uncertainty in the reported prevalence in the literature. OBJECTIVE To evaluate the completeness and accuracy of reporting postpartum migraine headache coding in health plan electronic health records (EHR) and compare the coding quality before and after implementation of the International Classification of Diseases-Clinical Modification [ICD]-10-CM coding and pharmacy records in EHR. METHODS Medical records of 200 pregnancies delivered in all Kaiser Permanente Southern California (KPSC) hospitals during two time periods: 1/1/2012 - 12/31/2014 (ICD-9-CM coding period) and 1/1/2017 - 12/31/2019 (ICD-10-CM coding period) were randomly selected from EHR for chart review, and postpartum migraine headache cases recorded within one year after delivery were identified. Abstracted clinical records for cases were compared with corresponding diagnosis and pharmacy prescription utilization records for both ICD-9-CM and ICD-10-CM coding periods through comparisons of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), as well as the summary statistics of F-score (F) and Youden’s J Statistic (J). Kappa statistic (K) for interrater reliability were calculated. RESULTS The overall interrater agreement among two chart abstractors for postpartum migraine headache was 100%. Diagnosis coding (F = 87.8%, J = 82.5%) did better than pharmacy records (F = 72.7%, J = 57.5%) when identifying cases, but combining both of these sources of data produced much greater accuracy identification of postpartum migraine cases (F = 96.9%, J = 99.7%). Results were similar across the ICD-9-CM and ICD-10-CM coding periods. CONCLUSIONS Neither diagnostic codes nor pharmacy records alone are sufficient for identifying postpartum migranie cases reliably, but when used together, they are quite reliable. The completeness of data remained similar after the implementation of the ICD-10-CM coding in the EHR system. CLINICALTRIAL Not Applicable.

  • Open Access

    Identification of Preterm Labor Evaluation Visits and Extraction of Cervical Length Measures from Electronic Health Records Within a Large Integrated Health Care System: Algorithm Development and Validation

    byĀ Fagen Xie, Nehaa Khadka, Michael J Fassett, Vicki Y Chiu, Chantal C Avila, Jiaxiao Shi, Meiyu Yeh, Aniket Kawatkar, Nana A Mensah, David A Sacks, et al.

    Background: Preterm birth (PTB) represents a significant public health problem in the United States and throughout the world. Accurate identification of preterm labor (PTL) evaluation visits is the first step in conducting PTB-related research. Objective: We aimed to develop a validated computerized algorithm to identify PTL evaluation visits and extract cervical length (CL) measures from electronic health records (EHRs) within a large integrated health care system. Methods: We used data extracted from the EHRs at Kaiser Permanente Southern California between 2009 and 2020. First, we identified triage and hospital encounters with fetal fibronectin (fFN) tests, transvaginal ultrasound (TVUS) procedures, PTL medications, or PTL diagnosis codes within 240/7-346/7 gestational weeks. Second, clinical notes associated with triage and hospital encounters within 240/7-346/7 gestational weeks were extracted from EHRs. A computerized algorithm and an automated process were developed and refined by multiple iterations of chart review and adjudication to search the following PTL indicators: fFN tests, TVUS procedures, abdominal pain, uterine contractions, PTL medications, and descriptions of PTL evaluations. An additional process was constructed to extract the CLs from the corresponding clinical notes of these identified PTL evaluation visits. Results: A total of 441,673 live birth pregnancies were identified between 2009 and 2020. Of these, 103,139 pregnancies (23.35%) had documented PTL evaluation visits identified by the computerized algorithm. The trend of pregnancies with PTL evaluation visits slightly decreased from 24.41% (2009) to 17.42% (2020). Of the first 103,139 PTL visits, 19,439 (18.85%) and 44,423 (43.97%) had an fFN test and a TVUS, respectively. The percentage of first PTL visits with an fFN test decreased from 18.06% at 240/7 gestational weeks to 2.32% at 346/7 gestational weeks, and TVUS from 54.67% at 240/7 gestational weeks to 12.05% in 346/7 gestational weeks. The mean (SD) of the CL was 3.66 (0.99) cm with a mean range of 3.61-3.69 cm that remained stable across the study period. Of the pregnancies with PTL evaluation visits, the rate of PTB remained stable over time (20,399, 19.78%). Validation of the computerized algorithms against 100 randomly selected records from these potential PTL visits showed positive predictive values of 97%, 94.44%, 100%, and 96.43% for the PTL evaluation visits, fFN tests, TVUS, and CL, respectively, along with sensitivity values of 100%, 90%, and 90%, and specificity values of 98.8%, 100%, and 98.6% for the fFN test, TVUS, and CL, respectively. Conclusions: The developed computerized algorithm effectively identified PTL evaluation visits and extracted the corresponding CL measures from the EHRs. Validation against this algorithm achieved a high level of accuracy. This computerized algorithm can be used for conducting PTL- or PTB-related pharmacoepidemiologic studies and patient care reviews.